226 related articles for article (PubMed ID: 32259456)
1. The potential and challenges of patient-derived organoids in guiding the multimodality treatment of upper gastrointestinal malignancies.
Busslinger GA; Lissendorp F; Franken IA; van Hillegersberg R; Ruurda JP; Clevers H; de Maat MFG
Open Biol; 2020 Apr; 10(4):190274. PubMed ID: 32259456
[TBL] [Abstract][Full Text] [Related]
2. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
[TBL] [Abstract][Full Text] [Related]
3. Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold.
Schmäche T; Fohgrub J; Klimova A; Laaber K; Drukewitz S; Merboth F; Hennig A; Seidlitz T; Herbst F; Baenke F; Ada AM; Groß T; Wenzel C; Ball CR; Praetorius C; Schmidt T; Ringelband-Schilling B; Koschny R; Stenzinger A; Roeder I; Jaeger D; Zeissig S; Welsch T; Aust D; Glimm H; Folprecht G; Weitz J; Haag GM; Stange DE
Mol Cancer; 2024 Jan; 23(1):10. PubMed ID: 38200602
[TBL] [Abstract][Full Text] [Related]
4. Development of a Single-Cell Technique to Increase Yield and Use of Gastrointestinal Cancer Organoids for Personalized Medicine Application.
Gao M; Harper MM; Lin M; Qasem SA; Patel RA; Mardini SH; Gabr MM; Cavnar MJ; Pandalai PK; Kim J
J Am Coll Surg; 2021 Apr; 232(4):504-514. PubMed ID: 33253861
[TBL] [Abstract][Full Text] [Related]
5. Patient-Derived Organoids from Locally Advanced Gastric Adenocarcinomas Can Predict Resistance to Neoadjuvant Chemotherapy.
Yoon C; Lu J; Kim BJ; Cho SJ; Kim JH; Moy RH; Ryeom SW; Yoon SS
J Gastrointest Surg; 2023 Apr; 27(4):666-676. PubMed ID: 36627466
[TBL] [Abstract][Full Text] [Related]
6. The effect of neoadjuvant chemotherapy and chemoradiotherapy on exercise capacity and outcome following upper gastrointestinal cancer surgery: an observational cohort study.
West MA; Loughney L; Ambler G; Dimitrov BD; Kelly JJ; Mythen MG; Sturgess R; Calverley PM; Kendrick A; Grocott MP; Jack S
BMC Cancer; 2016 Sep; 16(1):710. PubMed ID: 27589870
[TBL] [Abstract][Full Text] [Related]
7. Establishment of Patient-Derived Gastric Cancer Organoid Model From Tissue Obtained by Endoscopic Biopsies.
Song H; Park JY; Kim JH; Shin TS; Hong SA; Huda MN; Kim BJ; Kim JG
J Korean Med Sci; 2022 Jul; 37(28):e220. PubMed ID: 35851862
[TBL] [Abstract][Full Text] [Related]
8. Patient-derived organoids as a platform for modeling a patient's response to chemoradiotherapy in esophageal cancer.
Karakasheva TA; Gabre JT; Sachdeva UM; Cruz-Acuña R; Lin EW; DeMarshall M; Falk GW; Ginsberg GG; Yang Z; Kim MM; Diffenderfer ES; Pitarresi JR; Li J; Muir AB; Hamilton KE; Nakagawa H; Bass AJ; Rustgi AK
Sci Rep; 2021 Oct; 11(1):21304. PubMed ID: 34716381
[TBL] [Abstract][Full Text] [Related]
9. Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours.
Fusco P; Parisatto B; Rampazzo E; Persano L; Frasson C; Di Meglio A; Leslz A; Santoro L; Cafferata B; Zin A; Cimetta E; Basso G; Esposito MR; Tonini GP
BMC Cancer; 2019 Oct; 19(1):970. PubMed ID: 31638925
[TBL] [Abstract][Full Text] [Related]
10. Multicellular Modelling of Difficult-to-Treat Gastrointestinal Cancers: Current Possibilities and Challenges.
Hakuno SK; Michiels E; Kuhlemaijer EB; Rooman I; Hawinkels LJAC; Slingerland M
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328567
[TBL] [Abstract][Full Text] [Related]
11. Multimodality treatment of operable gastric and oesophageal adenocarcinoma: evaluating neoadjuvant, adjuvant and perioperative approaches.
Davidson M; Chau I
Expert Rev Anticancer Ther; 2018 Apr; 18(4):327-338. PubMed ID: 29431018
[TBL] [Abstract][Full Text] [Related]
12. Patient-derived organoids as individual patient models for chemoradiation response prediction in gastrointestinal malignancies.
Le Compte M; Komen N; Joye I; Peeters M; Prenen H; Smits E; Deben C; de Maat M
Crit Rev Oncol Hematol; 2021 Jan; 157():103190. PubMed ID: 33310278
[TBL] [Abstract][Full Text] [Related]
13. An Organoid-Based Preclinical Model of Human Gastric Cancer.
Steele NG; Chakrabarti J; Wang J; Biesiada J; Holokai L; Chang J; Nowacki LM; Hawkins J; Mahe M; Sundaram N; Shroyer N; Medvedovic M; Helmrath M; Ahmad S; Zavros Y
Cell Mol Gastroenterol Hepatol; 2019; 7(1):161-184. PubMed ID: 30522949
[TBL] [Abstract][Full Text] [Related]
14. Esophagogastric junction and gastric adenocarcinoma: neoadjuvant and adjuvant therapy, and future directions.
Sandler S
Oncology (Williston Park); 2014 Jun; 28(6):505-12. PubMed ID: 25134325
[TBL] [Abstract][Full Text] [Related]
15. Patient-derived organoid models help define personalized management of gastrointestinal cancer.
Aberle MR; Burkhart RA; Tiriac H; Olde Damink SWM; Dejong CHC; Tuveson DA; van Dam RM
Br J Surg; 2018 Jan; 105(2):e48-e60. PubMed ID: 29341164
[TBL] [Abstract][Full Text] [Related]
16. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection.
Cense HA; van Eijck CH; Tilanus HW
Best Pract Res Clin Gastroenterol; 2006; 20(5):893-906. PubMed ID: 16997168
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant therapy for gastrointestinal cancers.
Kelsen D
Oncology (Williston Park); 1993 Sep; 7(9):25-32; discussion 32, 35-6, 41. PubMed ID: 8217529
[TBL] [Abstract][Full Text] [Related]
18. Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer.
Seppälä TT; Zimmerman JW; Sereni E; Plenker D; Suri R; Rozich N; Blair A; Thomas DL; Teinor J; Javed A; Patel H; Cameron JL; Burns WR; He J; Tuveson DA; Jaffee EM; Eshleman J; Szabolcs A; Ryan DP; Ting DT; Wolfgang CL; Burkhart RA
Ann Surg; 2020 Sep; 272(3):427-435. PubMed ID: 32657929
[TBL] [Abstract][Full Text] [Related]
19. Organoid models of gastrointestinal cancers in basic and translational research.
Lau HCH; Kranenburg O; Xiao H; Yu J
Nat Rev Gastroenterol Hepatol; 2020 Apr; 17(4):203-222. PubMed ID: 32099092
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal cancer organoids-applications in basic and translational cancer research.
Seidlitz T; Stange DE
Exp Mol Med; 2021 Oct; 53(10):1459-1470. PubMed ID: 34663939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
